Harvard Apparatus Regenerative Technology, Inc. (HRGN) stock
HRGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.21−0.02 (-0.72%)
Close on Oct 19, 2026Market cap $40.13MP/E –Yield –
Harvard Apparatus Regenerative Technology operating margin
Operating margin is operating income as a percentage of revenue.
Harvard Apparatus Regenerative Technology's operating margin for the twelve months ending Sep 30, 2026 was -643.0%. For fiscal 2025 it was -982.2%, against -1796.7% the year before. The highest annual figure on record is -982.2% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -982.2% | +814.5 |
| FY2024 | Dec 31, 2024 | -1796.7% | +6931.4 |
| FY2023 | Dec 31, 2023 | -8728.2% | +6059.6 |
| FY2016 | Dec 31, 2016 | -14787.8% | −4871.7 |
| FY2015 | Dec 31, 2015 | -9916.1% | +1973.1 |
| FY2014 | Dec 31, 2014 | -11889.2% | +28188.0 |
| FY2013 | Dec 31, 2013 | -40077.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -1006.9% | +386.6 |
| Q2 FY2026 | Jun 30, 2026 | -408.7% | +169.5 |
| Q1 FY2026 | Mar 31, 2026 | -710.6% | +3000.5 |
| Q4 FY2025 | Dec 31, 2025 | -775.3% | −246.3 |
| Q3 FY2025 | Sep 30, 2025 | -1393.5% | +1757.4 |
| Q2 FY2025 | Jun 30, 2025 | -578.2% | +3852.1 |
| Q1 FY2025 | Mar 31, 2025 | -3711.1% | −165.5 |
| Q4 FY2024 | Dec 31, 2024 | -529.1% | +2372.5 |
| Q3 FY2024 | Sep 30, 2024 | -3150.8% | +909.2 |
| Q2 FY2024 | Jun 30, 2024 | -4430.4% | +8366.1 |
| Q1 FY2024 | Mar 31, 2024 | -3545.6% | – |
| Q4 FY2023 | Dec 31, 2023 | -2901.6% | – |
| Q3 FY2023 | Sep 30, 2023 | -4060.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -12796.4% | – |
See a number that looks wrong?